BFI Co., LLC 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Jul 19, 2018
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Sale
Class A Common Stock
2018-07-17$48.20/sh−9,470$456,454→ 38,000 total - Sale
Class A Common Stock
2018-07-18$47.95/sh−4,000$191,800→ 34,000 total - Conversion
Class A Common Stock
2018-07-17+17,470→ 47,470 total - Sale
Class A Common Stock
2018-07-19$47.22/sh−4,000$188,880→ 30,000 total - Conversion
Class B Common Stock
2018-07-17−17,470→ 20,318,034 totalExercise: $0.00→ Class A Common Stock (17,470 underlying)
Footnotes (5)
- [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.50,inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.75 to $48.40, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $47.40, inclusive.